News | August 28, 2013

VuComp M-Vu CAD System for Mammography Installed at Cancer Center in Richmond, Va.

August 28, 2013 — VuComp Inc. announced it has installed its advanced computer-aided detection (CAD) system, M-Vu CAD, at Allison Breast Center in Richmond, Va. The VuComp system, the first of its kind in Virginia, will analyze images from the clinic’s new Philips MicroDose Mammography system. Women in the region will have access to the world’s most advanced tools to help detect breast cancer as early as possible in order to achieve the best outcomes. VuComp’s M-Vu system analyzes mammographic images and marks suspicious areas using sophisticated mathematical algorithms.

“Our experience with VuComp’s CAD system has been extremely satisfactory in that it does not overcall and certainly is very sensitive to real abnormalities,” said Michael Bigg, M.D., JD, chief radiologist and owner of Allison Breast Center. “Earlier CAD systems with older software technology, which are still widely in use, certainly flag far too many abnormalities, reducing diagnostic confidence and wasting time.”

Bigg noted that VuComp CAD has also been an important aid in helping patients understand their situation — and in gaining their confidence. “Surprisingly, not all patients when shown an abnormality on a mammogram are comfortable with proceeding to an immediate biopsy, especially when these are small and more subtle. I spend a lot of time convincing reluctant patients of the need for biopsy. I’ve found that when I point out VuComp’s CAD marks on their mammogram it helps them to understand and become more comfortable with the recommendation.”

The VuComp system received U.S. Food and Drug Administration (FDA) approval to work with film mammography systems in January 2012, and a supplementary approval for digital mammography in October 2012. While CAD systems have been used in clinical practice since the mid-1990s, recent FDA guidelines have significantly raised the bar for CAD performance and now recommend comprehensive reader studies proving that radiologists are more effective when they use CAD. The VuComp system is the only FDA-approved mammography CAD product that meets these recommendations.

For more information:

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init